Mach7 Technologies Limited

Mach7 Technologies Limited

TDMMF
Mach7 Technologies LimitedUS flagOther OTC
0.24
USD
- -
- -
55.74MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
Revenue per Share
- -
- -
- -
0.01
0.03
0.09
0.07
0.07
0.11
0.08
0.08
0.08
0.07
Basic EPS, GAAP
-0.1
-0.23
-0.05
-0.35
-0.27
-0.16
-0.04
-0.05
- -
-0.04
-0.02
- -
-0.03
Free Cash Flow per Basic Share
- -
- -
- -
-0.03
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.35
0.11
0.09
0.08
0.4
0.12
0.08
0.05
0.29
0.22
0.22
0.22
0.19
Tangible Book Value per Share
0.35
0.11
0.09
0.16
-0.22
-0.02
- -
- -
0.28
0.06
0.08
0.12
0.12
Basic Weighted Avg Shares
4
4
6
20
54
112
130
143
170
235
238
239
241
Sales/Revenue/Turnover
- -
- -
- -
- -
2
10
9
9
19
19
19
20
17
Operating Margin (%)
- -
- -
- -
-1,051.17
-314.87
-106.55
-90.1
-80.28
-4.79
-55.03
-83.32
-84.74
-129.54
Depreciation Expense
- -
- -
- -
- -
2
6
4
4
4
10
9
9
7
Net Income, GAAP
- -
-1
- -
-7
-15
-18
-5
-7
- -
-9
-4
-1
-8
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-4,802.55
-783.46
-171.97
-57.3
-75.52
0.9
-49.18
-22.4
-5.17
-46.22
Working Capital
1
- -
1
3
-2
3
3
1
47
17
22
20
19
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
Total Equity
1
- -
1
3
23
16
14
10
54
63
62
63
56
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-26.17
-100.1
-60.03
-660.04
-125.23
-100.96
-41.16
-79.25
0.6
-18.31
-8
-2.02
-16.36

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
148.69%
84.83%
-11.36%
Free Cash Flow
- -
69.39%
8.39%
Net Income, GAAP
-291.09%
-1,039.9%
660.45%
Sales/Revenue/Turnover
- -
18.89%
-14.88%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
19
2023
- -
- -
- -
- -
20
2024
- -
- -
- -
- -
17

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.02
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
-0.03

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Teri Jo Thomas
Full Time Employees
58
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
120 Kimball Avenue South Burlington VT United States of America 05403
IPO Date
Dec 31, 2015
Website
mach7t.com
Business
Mach7 Technologies Limited (ASX:M7T; OTC:TDMMF) develops and commercializes enterprise medical imaging software solutions that enable healthcare organizations to manage, share, store, and interoperate clinical imaging and multimedia data across departments, sites, and vendors worldwide. The company offers a vendor-neutral platform including eUnity Enterprise Diagnostic Viewer for zero-footprint viewing and integration; Enterprise PACS for consolidated radiology imaging; vendor neutral archiving (VNA); UnityVue, a unified radiology workflow suite integrating image acquisition, worklists, and reporting; intelligent AI capabilities leveraging Strings for self-healing IT operations, workflow automation, and predictive analytics; enterprise data management for cross-workflow capture, indexing, distribution, and analysis; and professional services encompassing training, project management, clinical applications, support, and maintenance. Founded in 2007 and headquartered in South Burlington, Vermont, Mach7 Technologies operates primarily in North America, Asia-Pacific, the Middle East, and Europe, serving academic medical centers, multi-site health networks, and government entities with subscription-based recurring revenue models. Recent developments include a five-year A$10.2 million renewal contract with Sentara Healthcare for its Enterprise Imaging Platform and PACS services in December 2023; a five-year extension worth HK$81 million (A$15 million) with Hong Kong's Hospital Authority in September 2023 for VNA, eUnity support, and professional services; the launch of UnityVue in collaboration with NewVue announced ahead of RSNA 2025; establishment of a lower-cost engineering innovation hub in Asia to scale development and support high-growth markets; appointment of a Chief Innovation Officer to unify product and engineering teams; Q1 FY26 sales orders of A$2.6 million and annual recurring revenue run rate of A$23.5 million as of September 2025; and reaffirmed FY25 guidance projecting 15-25% revenue growth with operating expenditure increases below revenue levels.

Company News

APIChat
  • Mach7 Technologies to Showcase Enterprise Imaging Innovation and New eUnity Digital Pathology Capabilities at SIIM26

  • Mach7 Technologies Limited (TDMMF) Q3 2026 Earnings Call Transcript

  • Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript

  • Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript

  • Mach7 Technologies Limited (TDMMF) Shareholder/Analyst Call Transcript

  • Mach7 Technologies Launches New Flight Path for Medical Imaging - "from Archive to Architecture" at RSNA 2025

  • Mach7 Technologies Limited (TDMMF) Q1 2026 Earnings Call Transcript